Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04878991Unknown

Overture Metabolomics Non-Selection Study

Role: collaborator

NCT05633316Not ApplicableUnknown

Automated Intracytoplasmic Sperm Injection (ICSIA)

Role: collaborator

NCT02865681Not ApplicableCompleted

Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization

Role: lead

NCT00799929Not ApplicableCompleted

IVF Clinical Trial of Two Different Treatment Protocols.

Role: lead

All 4 trials loaded